BioCardias CardiAMP Autologous Cell Therapy for Ischemic Heart Failure Nears Approval in Japan
On December 2, 2023, BioCardia shared an exciting update following their consultation with Japan's PMDA regarding the groundbreaking CardiAMP Autologous ...